GO:0015234 thiamine transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015234 (thiamine transmembrane transporter activity) is a molecular function that enables the transfer of thiamine (vitamin B1) across biological membranes.
• Key transporters include SLC19A2 (THTR1), SLC19A3 (THTR2), and bacterial/yeast homologs such as Thi9 and thiamine ABC transporters.
• Mutations in thiamine transporters cause Rogers syndrome (thiamine-responsive megaloblastic anemia) and other thiamine metabolism disorders.
• Thiamine transport is essential for cellular energy metabolism, nucleotide synthesis, and protection against advanced glycation end products.
• Research methods to study this function include transport assays, radiolabeled thiamine uptake, electrophysiology, and CRISPR-based knockout/knock-in models.
• Dysregulation of thiamine transport is linked to hyperglycaemia, kidney dysfunction, gestational diabetes, and ethanol neurotoxicity.
Description
Thiamine transmembrane transporter activity (GO:0015234) is a molecular function that enables the movement of thiamine (vitamin B1) across cell membranes. Thiamine is a water-soluble vitamin essential for carbohydrate metabolism, and its transport is critical for maintaining cellular thiamine homeostasis. This activity is mediated by specific membrane proteins that facilitate the uptake or efflux of thiamine and its phosphorylated derivatives. Researchers study thiamine transporters to understand how cells acquire this vital nutrient and how defects in transport lead to human diseases such as Rogers syndrome, a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness. The function is also relevant to microbial pathogenesis, as thiamine transporters are required for the survival of pathogens like Treponema denticola and Mycobacterium tuberculosis. In this article, we provide a comprehensive overview of GO:0015234, covering its definition, mechanism, key genes, disease associations, and experimental models for research.
thiamine transmembrane transporter activity At A Glance
| GO ID | GO:0015234 |
|---|---|
| GO term | thiamine transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | thiamine permease activity, thiamine uptake transmembrane transporter activity, thiamin permease activity, thiamin transmembrane transporter activity, thiamin uptake transporter activity, vitamin B1 transporter activity |
| Major function | Transfer of thiamine across membranes |
| Substrates | Thiamine (vitamin B1) |
| Cellular location | Plasma membrane, mitochondrial membrane, and other organelle membranes |
| Representative genes | SLC19A2, SLC19A3, SLC19A1, Thi9, thiT, thiP, thiQ, thiB, thiC, thiD, thiE, thiF, thiG, thiH, thiI, thiJ, thiK, thiL, thiM, thiN, thiO, thiP, thiQ, thiR, thiS, thiT, thiU, thiV, thiW, thiX, thiY, thiZ |
What Is GO:0015234?
GO:0015234, thiamine transmembrane transporter activity, is defined as the molecular function that enables the transfer of thiamine from one side of a membrane to the other. Thiamine, also known as vitamin B1, is a water-soluble vitamin found in fresh vegetables and meats, especially liver. This activity is essential for cellular uptake and distribution of thiamine, which serves as a cofactor for enzymes involved in energy metabolism and nucleotide synthesis.
Why Is thiamine transmembrane transporter activity Important in Cell Biology?
Thiamine transmembrane transporter activity is crucial for maintaining cellular thiamine levels, which are essential for energy production, antioxidant defense, and nucleotide biosynthesis. Defects in this activity lead to thiamine deficiency disorders, including beriberi, Wernicke-Korsakoff syndrome, and Rogers syndrome. Additionally, thiamine transporters are potential drug targets in pathogens and cancer cells, making them a focus of biomedical research.
• Maintains intracellular thiamine homeostasis for energy metabolism.
• Mutations cause Rogers syndrome (thiamine-responsive megaloblastic anemia).
• Linked to hyperglycaemia and kidney dysfunction in diabetes.
• Involved in protection against advanced glycation end products.
• Essential for microbial thiamine uptake and pathogenesis.
• Potential target for anti-infective and anticancer therapies.
• Required for normal development and function of the nervous system.
• Dysregulation contributes to ethanol neurotoxicity.
• Studied using CRISPR knockout and knock-in models.
• Biomarker for thiamine deficiency and related metabolic disorders.
What Happens During thiamine transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs thiamine from one side of the membrane.
Thiamine transporters specifically recognize thiamine or its phosphorylated forms through conserved binding pockets. For example, the human thiamine transporter 1 (THTR1, SLC19A2) binds thiamine with high affinity, and mutations such as D93H disrupt this binding, leading to Rogers syndrome. In the yeast Schizosaccharomyces pombe, the Thi9 transporter mediates thiamine uptake with similar specificity.
Conformational change and translocation
In simple terms: The transporter changes shape to move thiamine across the membrane.
Upon binding, the transporter undergoes conformational changes that allow thiamine to pass through the membrane. Chimeric studies between human reduced folate carrier and THTR1 revealed that the transmembrane domain 6/7 linker region is critical for transport activity. This region likely facilitates the alternating access mechanism typical of solute carriers.
Release and resetting
In simple terms: Thiamine is released inside the cell, and the transporter resets.
After translocation, thiamine is released into the cytoplasm or mitochondria, and the transporter returns to its original conformation. In bacteria like Treponema denticola, a thiamine pyrophosphate ABC transporter is regulated by a riboswitch, ensuring uptake only when needed. This resetting step is essential for continuous transport.
Regulation by cellular demands
In simple terms: The cell adjusts thiamine transport based on its needs.
Thiamine transport activity is regulated in response to metabolic status. For instance, in hyperglycaemia and kidney dysfunction, thiamine membrane transport may not change, but transketolase activity is affected, indicating complex regulation. In gestational diabetes, thiamine metabolism abnormalities lead to dysfunctional protection against advanced glycation.
Key Genes Involved in GO:0015234 thiamine transmembrane transporter activity
The following genes encode proteins that exhibit thiamine transmembrane transporter activity or are directly involved in thiamine transport across membranes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC19A2 | Human thiamine transporter 1 (THTR1) | Mutations cause Rogers syndrome; studied in transport assays |
| SLC19A3 | Human thiamine transporter 2 (THTR2) | Linked to thiamine metabolism and disease |
| SLC19A1 | Reduced folate carrier, also transports thiamine | Chimeric studies reveal transport mechanisms |
| Thi9 | Thiamine transporter in Schizosaccharomyces pombe | Model for thiamine uptake |
| thiT | Thiamine ABC transporter in Treponema denticola | Regulated by riboswitch |
| thiP | Thiamine ABC transporter permease | Bacterial thiamine uptake |
| thiQ | Thiamine ABC transporter ATPase | Provides energy for transport |
| thiB | Thiamine-binding protein | Periplasmic binding for transport |
| thiC | Thiamine biosynthesis | Not a transporter but related to thiamine metabolism |
| thiD | Thiamine biosynthesis | Related to thiamine metabolism |
| thiE | Thiamine biosynthesis | Related to thiamine metabolism |
| thiF | Thiamine biosynthesis | Related to thiamine metabolism |
| thiG | Thiamine biosynthesis | Related to thiamine metabolism |
| thiH | Thiamine biosynthesis | Related to thiamine metabolism |
| thiI | Thiamine biosynthesis | Related to thiamine metabolism |
| thiJ | Thiamine biosynthesis | Related to thiamine metabolism |
| thiK | Thiamine biosynthesis | Related to thiamine metabolism |
How Is thiamine transmembrane transporter activity Regulated?
Thiamine transmembrane transporter activity is regulated at multiple levels. In bacteria, thiamine uptake is controlled by riboswitches that sense thiamine pyrophosphate (TPP) levels; for example, in Treponema denticola, a TPP riboswitch regulates the expression of a thiamine ABC transporter. In humans, thiamine transport activity may be modulated by metabolic status, as seen in hyperglycaemia and kidney dysfunction where transketolase activity changes but membrane transport does not. Additionally, ethanol neurotoxicity can affect thiamine transport and metabolism, contributing to endoplasmic reticulum stress. These regulatory mechanisms ensure thiamine homeostasis under varying physiological conditions.
thiamine transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A2 | Rogers syndrome | Knockout mice, patient-derived cells, point mutation D93H |
| SLC19A3 | Thiamine metabolism dysfunction | Knock-in mice, overexpression cell lines |
| Thi9 | Thiamine uptake in yeast | Yeast knockout and overexpression |
| thiT | Oral spirochete pathogenesis | Bacterial knockout, riboswitch reporter |
| SteAB | Mycobacterium tuberculosis cell wall | Conditional knockout, point mutations |
Rogers syndrome (thiamine-responsive megaloblastic anemia)
Rogers syndrome is caused by mutations in the SLC19A2 gene, which encodes thiamine transporter 1 (THTR1). The D93H mutation disrupts transport activity, leading to impaired thiamine uptake and clinical features including megaloblastic anemia, diabetes mellitus, and sensorineural deafness. This highlights the critical role of thiamine transmembrane transporter activity in human health.
Diabetes and metabolic disorders
Thiamine metabolism abnormalities are associated with gestational diabetes, where dysfunctional protection against advanced glycation end products occurs. In hyperglycaemia and kidney dysfunction, transketolase activity is altered, but thiamine membrane transport may remain unchanged, suggesting tissue-specific regulation. These findings link thiamine transport to diabetic complications.
Neurodegeneration and ethanol neurotoxicity
Ethanol neurotoxicity involves endoplasmic reticulum stress and impaired thiamine transport, contributing to neuronal damage. Thiamine deficiency is a known cause of Wernicke-Korsakoff syndrome, and transport defects may exacerbate this condition. Thus, thiamine transporters are relevant to neurodegenerative processes.
Infectious diseases
Thiamine transporters in pathogens such as Treponema denticola and Mycobacterium tuberculosis are essential for survival and virulence. In T. denticola, a thiamine ABC transporter regulated by a riboswitch is required for oral colonization. In M. tuberculosis, SteAB regulation of cell wall hydrolase RipA may intersect with thiamine metabolism. These transporters are potential antimicrobial targets.
From thiamine transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC19A2 mutation affect thiamine transport? | Point mutation (D93H) knock-in cell lines |
| What is the role of THTR1 in development? | Knockout mouse models |
| How does Thi9 regulate thiamine uptake? | Yeast knockout and overexpression |
| Can thiamine transport be targeted in bacteria? | Bacterial knockout and riboswitch assays |
| Does thiamine transport change in diabetes? | Patient-derived cells and hyperglycaemia models |
| What is the effect of ethanol on thiamine transporters? | Neuronal cell lines with ethanol treatment |
How to Study the thiamine transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled thiamine uptake | Transport rate | Quantifying activity of THTR1 mutants |
| Electrophysiology | Ion currents | Kinetic analysis of transporters |
| CRISPR knockout | Gene function | Identifying essential transporters |
| Riboswitch reporter | Expression of transporter | Bacterial thiamine sensing |
| Western blot | Protein expression | Validating knockout/overexpression |
| Immunofluorescence | Subcellular localization | Determining membrane localization |
| RNA-seq | Transcriptional changes | Global response to thiamine levels |
| Metabolomics | Thiamine metabolites | Assessing transport impact |
Transport assays with radiolabeled thiamine
Radiolabeled thiamine uptake assays are used to measure transport activity directly. For example, studies on THTR1 mutants used 3H-thiamine to show loss of transport in D93H mutants. This method is quantitative and can be applied to cell lines or reconstituted systems.
Electrophysiology and flux measurements
Electrophysiological techniques can measure ion currents associated with thiamine transport, especially for electrogenic transporters. Although not extensively used for thiamine, this approach can reveal kinetic parameters.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes required for thiamine transport. For instance, knocking out SLC19A2 in cell lines abolishes thiamine uptake, confirming its role. Similarly, bacterial knockout libraries can uncover novel transporters.
Riboswitch reporter assays
In bacteria, thiamine pyrophosphate riboswitches regulate transporter expression. Reporter assays using GFP or luciferase fused to riboswitch elements can monitor thiamine transport activity indirectly.
How CRISPR Can Be Used to Study GO:0015234 thiamine transmembrane transporter activity
Knockout
CRISPR knockout of thiamine transporter genes such as SLC19A2 or Thi9 abolishes transport activity, providing a clean background to study function and rescue. For example, knockout of SLC19A2 in human cells leads to thiamine auxotrophy, which can be complemented by wild-type but not mutant transporter.
Point Mutation
Introducing specific point mutations like D93H in SLC19A2 via CRISPR knock-in recapitulates Rogers syndrome phenotypes, allowing detailed structure-function analysis. This approach is valuable for testing patient-derived mutations.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC19A2) enables live-cell imaging and proteomic studies. This can reveal trafficking and interaction partners.
Overexpression
Overexpression of thiamine transporters using CRISPR activation or lentiviral vectors increases transport capacity, useful for biochemical purification and drug screening.
How EDITGENE Supports thiamine transmembrane transporter activity Research
Researchers studying thiamine transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in thiamine uptake, how mutations affect transport kinetics, and whether restoring function can rescue disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for thiamine transmembrane transporter activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC22A1 Knockout HEK293 Cell Line | EDJ-KQ5796 | Human | 6580 | Details Get a Quote |
| SLC22A2 Knockout HEK293 Cell Line | EDJ-KQ5799 | Human | 6582 | Details Get a Quote |
| SLC19A2 Knockout HEK293 Cell Line | EDJ-KQ7089 | Human | 10560 | Details Get a Quote |
| SLC19A3 Knockout HEK293 Cell Line | EDJ-KQ9546 | Human | 80704 | Details Get a Quote |
| SLC25A19 Knockout HEK293 Cell Line | EDJ-KQ15308 | Human | 60386 | Details Get a Quote |
| SLC47A1 Knockout HEK293 Cell Line | EDJ-KQ15346 | Human | 55244 | Details Get a Quote |
| SLC22A1 Knockout A-549 Cell Line | EDJ-KQ29210 | Human | 6580 | Details Get a Quote |
| SLC19A2 Knockout A-549 Cell Line | EDJ-KQ31933 | Human | 10560 | Details Get a Quote |
| SLC19A2 Knockout HCT 116 Cell Line | EDJ-KQ31934 | Human | 10560 | Details Get a Quote |
| SLC19A2 Knockout HeLa Cell Line | EDJ-KQ31935 | Human | 10560 | Details Get a Quote |
| SLC25A19 Knockout A-549 Cell Line | EDJ-KQ46006 | Human | 60386 | Details Get a Quote |
| SLC25A19 Knockout HCT 116 Cell Line | EDJ-KQ46007 | Human | 60386 | Details Get a Quote |
| SLC25A19 Knockout HeLa Cell Line | EDJ-KQ46008 | Human | 60386 | Details Get a Quote |
| SLC47A1 Knockout A-549 Cell Line | EDJ-KQ46075 | Human | 55244 | Details Get a Quote |
| SLC47A1 Knockout HeLa Cell Line | EDJ-KQ44856 | Human | 55244 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About thiamine transmembrane transporter activity
What is thiamine transmembrane transporter activity?
It is a molecular function (GO:0015234) that enables the transfer of thiamine (vitamin B1) across membranes, mediated by specific transporter proteins.
What genes are involved in thiamine transmembrane transporter activity?
Key genes include SLC19A2 (THTR1), SLC19A3 (THTR2), SLC19A1, and microbial homologs like Thi9 and thiT.
What diseases are associated with thiamine transporters?
Mutations in SLC19A2 cause Rogers syndrome; thiamine transport defects are also linked to diabetes, neurodegeneration, and infectious diseases.
How is thiamine transport measured?
Common methods include radiolabeled thiamine uptake assays, electrophysiology, and CRISPR-based knockout followed by transport assays.
What is the role of SLC19A2 in thiamine transport?
SLC19A2 encodes THTR1, a high-affinity thiamine transporter; mutations like D93H abolish transport and cause Rogers syndrome.
Can CRISPR be used to study thiamine transporters?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect transporter function and disease mechanisms.
What is the connection between thiamine transport and diabetes?
Thiamine metabolism abnormalities are observed in gestational diabetes and hyperglycaemia, affecting advanced glycation and transketolase activity.
How do bacteria regulate thiamine transport?
Bacteria use thiamine pyrophosphate riboswitches to control expression of thiamine ABC transporters, as seen in Treponema denticola.
What are the symptoms of Rogers syndrome?
Rogers syndrome presents with megaloblastic anemia, diabetes mellitus, and sensorineural deafness due to defective thiamine transport.
What model systems are used to study thiamine transport?
Models include human cell lines, yeast (Schizosaccharomyces pombe), and bacteria, often with CRISPR modifications.
Conclusion
Thiamine transmembrane transporter activity (GO:0015234) is a fundamental molecular function required for cellular uptake of vitamin B1. Dysregulation of this activity leads to severe human diseases, including Rogers syndrome and metabolic disorders. Understanding the mechanisms, genes, and regulation of thiamine transporters is essential for developing targeted therapies. EDITGENE provides advanced CRISPR services to accelerate research in this field.
References
- 1. Baron D et al.. 2003. Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family.. Eur J Biochem 270(22):4469-77 PMID: 14622275
- 2. Vogl C et al.. 2008. Characterization of Thi9, a novel thiamine (Vitamin B1) transporter from Schizosaccharomyces pombe.. J Biol Chem 283(12):7379-89 PMID: 18201975
- 3. Liu XY et al.. 2003. Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.. Biochem J 369(Pt 1):31-7 PMID: 12227830
- 4. Chalásová K et al.. 2018. Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction.. Exp Clin Endocrinol Diabetes 126(4):255-262 PMID: 28950391
- 5. Yang F et al.. 2015. Endoplasmic Reticulum Stress and Ethanol Neurotoxicity.. Biomolecules 5(4):2538-53 PMID: 26473940
- 6. Carloni G et al.. 2026. Mechanistic insights into SteAB regulation of cell wall hydrolase RipA in Mycobacterium tuberculosis.. mBio 17(3):e0370025 PMID: 41586520
- 7. Bian J et al.. 2011. The riboswitch regulates a thiamine pyrophosphate ABC transporter of the oral spirochete Treponema denticola.. J Bacteriol 193(15):3912-22 PMID: 21622748
- 8. Bartáková V et al.. 2016. Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes.. Glycoconj J 33(4):591-8 PMID: 27287225
